1. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. United States Centers for Disease Control and Prevention. Accessed May 7, 2009.
http://www.cdc.gov/h1n1flu/recommendations.htm.
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Eng J Med. 2009. 361.
4. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagoski S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L. Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005-2009. N Eng J Med. 2009. 361.
Article
5. Cate TR, Kasel JA, Couch RB, Six HR, Knight V. Clinical trials of bivalent influenza A/New Jersey/76-A/Victoria/75 vaccines in the elderly. J Infect Dis. 1977. 136:Suppl. S518–S525.
Article
6. Dolin R, Wise TG, Mazur MH, Tuazon CU, Ennis FA. Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis. 1977. 136:Suppl. S435–S442.
Article
7. Jordan H, Mosquera M, Nair H, France A. Swine-origin influenza A (H1N1) virus infections in a school-New York City, April 2009. MMWR Morb Mortal Wkly Rep. 2009. 58(Dispatch):1–3.
8. Centers for Disease Control and Prevention (CDC). Update: novel influenza A (H1N1) virus infections-worldwide, May 6, 2009.
9. Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection---Mexico, March--April 2009. MMWR Morb Mortal Wkly Rep. 2009. 58:467.
10. Centers for Disease Control and Prevention (CDC). ONovel influenza A (H1N1) virus infections in three pregnant women-United States, April-May 2009. MMWR Morb Mortal Wkly Rep. 2009. 58:497–500.
11. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009. 58:433–435.